Login to Your Account



Pharma: Other News To Note


Friday, November 8, 2013
• Alvogen Pharma US Inc., of Pine Brook, N.J., said it finalized a transaction with Shionogi & Co. Ltd., of Osaka, Japan, acquiring the exclusive rights to commercialize Naprelan (naproxen sodium) controlled-release tablets in the U.S.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription